In this small trial of patients post ischemic stroke, they were randomized to fluoxetine or placebo for 3 months; those in the fluoxetine group improved significantly more on motor scales than those in the placebo group. In patients with motor deficits and need for anti-depressants post-stroke, fluoxetine may be a good choice (abstract)
Dr. Scheurer is a clinical hospitalist and the Medical Director of Quality and Safety at the Medical University of South Carolina in Charleston, South Carolina, and is Assistant Professor of Medicine. She is a graduate of the University of Tennessee College of Medicine, completed her residency at Duke University, and completed her Masters in Clinical Research at the Medical University of South Carolina. She also serves as the Web Editor and Physician Advisor for the Society of Hospital Medicine.